Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT
一项针对接受HLA匹配无关供者造血干细胞移植患者的高剂量帕利夫明预防移植物抗宿主病(GVHD)的I/II期研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024028303
Schulz, Eduard; Curtis, Lauren M; Holtzman, Noa G; Steinberg, Seth M; Wloka, Kaska; Ostojic, Alen; Mina, Alain; El Jurdi, Najla; Pirsl, Filip; Carpenter, Ashley; Golagha, Mahshid; Sirajuddin, Arlene; Heller, Theo; Shaffer, Brian C; Hakim, Frances T; Rubin, Jeffrey S; Gress, Ronald E; Pavletic, Steven Z